Equities
  • Price (EUR)0.132
  • Today's Change-0.004 / -2.94%
  • Shares traded0.00
  • 1 Year change-79.38%
  • Beta--
Data delayed at least 15 minutes, as of Apr 19 2024 07:06 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

EC Healthcare is an investment holding company principally engaged in the provision of medical and healthcare services. The Company operates its business through three segments. The Medical Services segment provides medical services,dental services and others. The Aesthetic Medical and Beauty and Wellness segment provides aesthetic medicine, traditional beauty, hair care and supplemental wellness services and sale of skin care, health and beauty products. The Other segment provides marketing and related services and veterinary services.

  • Revenue in HKD (TTM)4.10bn
  • Net income in HKD-3.74m
  • Incorporated2015
  • Employees2.72k
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
2138:HKG since
announced
Transaction
value
SILK Laser Australia LtdDeal withdrawn23 May 202323 May 2023Deal withdrawn-73.50%118.39m
Data delayed at least 15 minutes, as of Apr 19 2024 09:08 BST.
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.